Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Infinityon Jun 22, 2022 8:07am
205 Views
Post# 34773261

RE:RE:RE:RE:RE:RE:RE:Dr. Arkady Mandel said

RE:RE:RE:RE:RE:RE:RE:Dr. Arkady Mandel saidThank you Cancer Slayer for explaining the difficulty in the different types of treatments and immune system's responses.   Very precise and easy to understand.   I gather that
1. PDT developed by our little company offers a very viable treatment if not a complete cure. 
2. The PDT can be repeated for certain patients who do not respond as well to the initial treatment
3. PDT has little or no "really bad" side effects that ar lasting in duration.
4. PDT can be administed with very low costs compared to other treatment options that are currently available.
5.  Fairly easy (No cancer treatment is easy) to administer during a day-visit to the hospital.
6.  Has measurable responses on a very difficult to treat group of people who have tried and failed other treatment options.

Cancer slayer again thank you for your contribution to this board during the period leading up to a very crucial AGM.  

By all considerations, we seem to have a winning formula!!!.  I have only one question.  Why are we still trading like any other penny stock??
GLTA
<< Previous
Bullboard Posts
Next >>